Kyle Doherty
Advertisement
Kyle Doherty joined MJH Life Sciences in 2021 and is the lead editor for Oncology Fellows. He also produces print content for OncologyLive, as well as news and conference updates for OncLive.com. Email: kdoherty@mjhlifesciences.com
Articles by Kyle Doherty
Advertisement
Latest Updated Articles
Perioperative Chemotherapy Prolongs OS vs Neoadjuvant Chemoradiation in Esophageal CancerPublished: June 2nd 2024 | Updated: June 3rd 2024
CA19-9 Plus Liquid Biopsy Represents Diagnostic Biomarker of Interest for Early-Stage Pancreatic Cancer DetectionPublished: March 19th 2025 | Updated:
ICI Use Does Not Significantly Affect EOL Outcomes in HCCPublished: October 29th 2025 | Updated:
Axi-cel Elicits Durable Response in Relapsed/Refractory FLPublished: June 16th 2021 | Updated:
ChatGPT Fails to Provide Up-to-Date and Specific Information for Specific Queries in Hematologic MalignanciesPublished: November 6th 2025 | Updated:
Adjuvant Ribociclib Plus AI Therapy Has Long-Term Activity in HR+, HER2-Negative Early Breast CancerPublished: October 17th 2025 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
5